[1]吴亚姗,万娟,杨力强.中药复方拆方研究概况[J].西部中医药,2022,35(07):126-129.[doi:10.12174/j.issn.2096-9600.2022.07.33]
　WU Yashan,WAN Juan,YANG Liqiang.Research Situations of Decomposing Herbal Compound[J].Western Journal of Traditional Chinese Medicine,2022,35(07):126-129.[doi:10.12174/j.issn.2096-9600.2022.07.33]
点击复制

中药复方拆方研究概况
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年07期
页码:
126-129
栏目:
研究进展
出版日期:
2022-07-15

文章信息/Info

Title:
Research Situations of Decomposing Herbal Compound
作者:
吴亚姗1, 万娟1, 杨力强1,2
1.广西中医药大学，广西 南宁 530200
2.广西中医基础研究重点实验室
Author(s):
WU Yashan1, WAN Juan1, YANG Liqiang1,2
1.Guangxi University of Chinese Medicine, Nanning 530200, China
2.Guangxi Key Laboratory of TCM Basic Research
关键词:
中药复方; 拆方; 方剂学; 综述
Keywords:
herbal compound; decomposed prescription; science of prescriptions; review
分类号:
R285.5
DOI:
10.12174/j.issn.2096-9600.2022.07.33
文献标志码:
A
摘要:
探讨中药复方拆方的目的与方法，增效减毒是方剂配伍的目的；以“法依病机、拆方依法”为前提将方剂进行拆解，通过对比全方、拆方、药对、单味药的治疗效果，从而探索方剂的配伍机理；而从拆方入手研究药物之间的相互作用，可缩小中医药的靶向治疗范围，也为方剂学的配伍研究提供新思路。
Abstract:
By discussing the purpose and method of decomposed herbal compound, enhancing effects and reducing toxicity is the aim of the compatibility in the prescription; the prescriptions are decomposed on the premise of “the compatibility law follow the pathogenesis, decomposing prescription abide by the law”, the compatibility mechanism of the prescription is explored by comparing therapeutic effects of the whole prescription, decomposed prescription, drug pairs and single herb; The studies on the interactions between drugs by decomposing prescriptions could reduce the scope of targeted treatment of TCM, and it could provide new thinking for the study on the compatibility of the science of prescriptions.

相似文献/References:

[1]唐瑛,肖力强,江花,等.中药复方敷擦外治类风湿性关节炎的用药规律研究*[J].西部中医药,2013,26(05):57.
　TANG Ying,XIAO Liqiang,JIANG Hua,et al.Research on the Law of Medicine Application of TCM Compound in Treating Rheumatoid Arthritis for External Use[J].Western Journal of Traditional Chinese Medicine,2013,26(07):57.
[2]马红,王海红Δ,蒲小庆,等.中西医结合治疗 2 型糖尿病 68 例[J].西部中医药,2014,27(08):95.
[3]宋玉,姜晨.中药干预CKD血管钙化的研究进展[J].西部中医药,2020,33(03):150.[doi:10.12174/j.issn.1004-6852.2020.03.43]
　SONG Yu,JIANG Chen.Research Progress on Materia Medica in the Intervention of CKD Vascular Calcification[J].Western Journal of Traditional Chinese Medicine,2020,33(07):150.[doi:10.12174/j.issn.1004-6852.2020.03.43]
[4]马思遥,任延毅,王雪冰,等.养阴活血类中药复方治疗放射性肺炎的Meta分析[J].西部中医药,2023,36(01):70.[doi:10.12174/j.issn.2096-9600.2023.01.17]
　MA Siyao,REN Yanyi,WANG Xuebing,et al.Meta-analysis of Compound Traditional Chinese Medicine of Nourishing-Yin and Promoting Blood Circulation in the Treatment of Radioactive Pneumonia[J].Western Journal of Traditional Chinese Medicine,2023,36(07):70.[doi:10.12174/j.issn.2096-9600.2023.01.17]
[5]潘谊,吴辉坤.基于毒痰瘀虚理论探讨中药复方对肝癌血管生成的影响[J].西部中医药,2023,36(03):24.[doi:10.12174/j.issn.2096-9600.2023.03.05]
　PAN Yi,WU Huikun.The Effects of Herbal Compound on Hepatocellular Carcinoma Angiogenesis Based on the Theory of Toxin/Phlegm/Stagnation-induced Deficiency[J].Western Journal of Traditional Chinese Medicine,2023,36(07):24.[doi:10.12174/j.issn.2096-9600.2023.03.05]
[6]陈一凡,李雁,褚岩,等.慢性阻塞性肺疾病的中药复方治疗专利现状及用药规律[J].西部中医药,2023,36(11):84.[doi:10.12174/j.issn.2096-9600.2023.11.19]
　CHEN Yifan,LI Yan,CHU Yan,et al.Patent Status of Chinese Medicine Compound for the Treatment of COPD and Medication Rules[J].Western Journal of Traditional Chinese Medicine,2023,36(07):84.[doi:10.12174/j.issn.2096-9600.2023.11.19]
[7]杜少鹏,刘维.中药防治痛风和高尿酸血症的研究进展[J].西部中医药,2024,37(07):87.[doi:10.12174/j.issn.2096-9600.2024.07.21]
　DU Shaopeng,LIU Wei.Progress of Research on the Prevention and Treatment of Gout and Hyperuricemia with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2024,37(07):87.[doi:10.12174/j.issn.2096-9600.2024.07.21]

备注/Memo

备注/Memo:
吴亚姗（1992—），女，硕士学位。研究方向：方剂配伍规律及方证研究。国家自然科学基金（81560748）；广西自然科学基金（2013GXNSFAA019128，2018GXNSFAA050079）。
更新日期/Last Update: 2022-07-15